Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies
Jinqiu Yuan, Qiangsheng He, Long H. Nguyen, et al.
Gut (2020) Vol. 70, Iss. 6, pp. 1070-1077
Closed Access | Times Cited: 57

Showing 26-50 of 57 citing articles:

Widening spectrum of adverse effects caused by long-term use of proton pump inhibitors: A comprehensive review of literature
AS Mir, Zahoor A. Wani, Ajmal R. Baht, et al.
LabMed discovery. (2024), pp. 100027-100027
Open Access | Times Cited: 1
Potential Therapeutic Targeting Neurotransmitter Receptors in Diabetes
Xiaohui Pan, Shibing Tao, Nanwei Tong
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 7
Risk stratification for proton pump inhibitor-associated type 2 diabetes: a population-based cohort study
Qiangsheng He, Man Yang, Xiwen Qin, et al.
Gut (2020) Vol. 70, Iss. 11, pp. 2215.2-2216
Closed Access | Times Cited: 9
Long-term use of proton pump inhibitors (PPIs) is associated with an increased risk of type 2 diabetes
Sven H. Loosen, Karel Kostev, Mark Luedde, et al.
Gut (2021), pp. gutjnl-326297
Closed Access | Times Cited: 9
Will Proton Pump Inhibitors Increase the Risk of Diabetes Mellitus? A Systemic Review and Meta-Analysis
Yue Chen, Lei Hu, Chenyu Sun, et al.
The Turkish Journal of Gastroenterology (2022)
Open Access | Times Cited: 6
Long-term Use of Proton Pump Inhibitors is Associated With An Increased Risk of Nonalcoholic Fatty Liver Disease
Hangkai Huang, Zhening Liu, Yanjun Guo, et al.
Journal of Clinical Gastroenterology (2023) Vol. 58, Iss. 3, pp. 289-296
Closed Access | Times Cited: 3
Prediction of New-Onset Diabetes Mellitus within 12 Months after Liver Transplantation—A Machine Learning Approach
Sven H. Loosen, Sarah Krieg, Saket Chaudhari, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4877-4877
Open Access | Times Cited: 3
Association between Urolithiasis and History Proton Pump Inhibitor Medication: A Nested Case-Control Study
So Young Kim, Dae Myoung Yoo, Woo Jin Bang, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5693-5693
Open Access | Times Cited: 3
Proton Pump Inhibitor Prescribing and Monitoring Patterns Among Gastroenterology Practitioners
David A. Leiman, Karthik Ravi, Daniel E. Freedberg, et al.
Journal of Clinical Gastroenterology (2021) Vol. 56, Iss. 7, pp. 571-575
Closed Access | Times Cited: 4
PPI use associated with decreased new-onset diabetes risk in Korean NHIS-HEALS cohort
Ye-Seul Kim, Jeong Sook Kim, Hyo‐Sun You, et al.
Research Square (Research Square) (2024)
Open Access
Side effects of proton pump inhibitors with long-term use: focus on the urinary system
Д. И. Трухан, И. А. Викторова
Medical alphabet (2024), Iss. 5, pp. 36-42
Closed Access
Cardiovascular risk with long-term use of proton pump inhibitors: myth or reality. A review
Д. И. Трухан, С. Н. Филимонов
Consilium Medicum (2024) Vol. 26, Iss. 1, pp. 55-60
Open Access
Long-Term Administration of Omeprazole-Induced Hypergastrinemia and Changed Glucose Homeostasis and Expression of Metabolism-Related Genes
Alina Kabaliei, Vitalina Palchyk, O. V. Izmailova, et al.
BioMed Research International (2024) Vol. 2024, pp. 1-16
Open Access
Acupoint catgut embedding advantage in treating gastro-oesophageal reflux disease (ACE-GERD): study protocol for a randomised controlled trial
Shuting Wen, Xiying Zhao, Xiaofeng Lin, et al.
BMJ Open (2024) Vol. 14, Iss. 10, pp. e081059-e081059
Open Access
Classification and identification of risk factors for type 2 diabetes
Shanshan Tang, Xuefei Zhao, Xuedong An, et al.
World Journal of Diabetes (2024) Vol. 16, Iss. 2
Closed Access
Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study
Ming‐Hsun Lin, Wen‐Tung Wu, Yong‐Chen Chen, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Confounded association between proton pump inhibitor use and risk of biliary tract cancer: Result from three cohorts
Qiangsheng He, Chongfei Huang, Xiwen Qin, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 5, pp. 942-949
Closed Access | Times Cited: 1
Different approaches to change gut microbiota and its influence on metabolic disorders
Ekaterina А. Shestakova, E. V. Pokrovskaya, Margarita Samsonova
Consilium Medicum (2021) Vol. 23, Iss. 12, pp. 905-909
Open Access | Times Cited: 3
UŞAK EĞİTİM VE ARAŞTIRMA HASTANESİ’NE BAŞVURAN HASTALARDA PROTON POMPA İNHİBİTÖRÜ KULLANIM YAYGINLIĞININ İNCELENMESİ
Baran ÖZDEMİR, Karya Başak ÖN, Ezgi ALTINER
Ege Tıp Bilimleri Dergisi (2022) Vol. 5, Iss. 1, pp. 11-15
Open Access | Times Cited: 2
Is an optimization of the use of proton pump inhibitors feasible in the real world medical practice?
Natalia M. Khomeriki, Sergey G. Khomeriki
Almanac of Clinical Medicine (2022) Vol. 50, Iss. 6, pp. 357-366
Open Access | Times Cited: 2
Seven days in medicine: 23-29 September 2020

BMJ (2020), pp. m3770-m3770
Closed Access | Times Cited: 1
Omeprazole prescriptions for older adults in health care units in Curitiba, Brazil: an analysis based on Beers Criteria
Juliana Sambugaro, Hudson Prestes dos Santos, Linda Tieko Kakitani Morishita, et al.
Geriatrics Gerontology and Aging (2021) Vol. 15
Open Access | Times Cited: 1
“Chronic Exposure to Proton Pump Inhibitor use and Diabetes Mellitus Incidence. A Systemic Review and Meta-Analysis “
Santenna Chenchula, PHULEN Sharma, Mohan Krishna Ghanta, et al.
Research Square (Research Square) (2023)
Open Access
Antacids in real clinical practice
Д. И. Трухан, Е. Н. Деговцов, A. Yu. Novikov
Meditsinskiy sovet = Medical Council (2023), Iss. 8, pp. 59-67
Open Access
Proton Pump Inhibitors Use and Risks of Cardiovascular Disease and Mortality in Patients with Type 2 Diabetes: A Prospective Study in the UK Biobank
Tingting Geng, Junxiang Chen, Yanfeng Zhou, et al.
Research Square (Research Square) (2022)
Open Access

Scroll to top